Drugs / Bicanova
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03994471 Comparator | Dec 2022 → Dec 2026 expected | end stage renal failure | Iperboreal Pharma Srl | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bicanova | “Balance, Bicavera, Bicanova or Equibalance have 1.25%, 2.3%, 4.5% glucose” NCT03994471 ↗ |